Skip to main content

Table 1 Patients' characteristics

From: Intrinsic resistance to tyrosine kinase inhibitors is associated with poor clinical outcome in metastatic renal cell carcinoma

  

n (%)

Sex

male

26 (74.3)

 

female

9 (25.7)

 

total

35 (100)

MSKCC risk

favourable

2 (5.7)

 

intermediate

21 (60.0)

 

poor

4 (11.4)

 

unknown

8 (22.9)

ECOG status

0

21 (60)

 

1

9 (25.7)

 

> 1

1 (2.9)

 

unknown

4 (11.4)

Histology

clear cell

29 (82.7)

 

papillary

4 (11.4)

 

other

2 (5.9)

Previous immunotherapy

14 (40)

  1. Abbreviations:
  2. MSKCC - Memorial Sloan-Kettering Cancer Center;
  3. ECOG - Eastern Cooperative Oncology Group;
  4. rTKI - receptor tyrosine kinase inhibitor.
Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us